PROCEPT BioRobotics Corporation Announces Pricing of Upsized Initial Public Offering

REDWOOD CITY, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (PROCEPT), a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced…

Click here to view the original article.